logo

  • The Company
    The Company
      • Promore Pharma in Brief
      • Vision and Strategy
      • Market
      • Team
      • Board of Directors
  • Projects
    Projects
      • Project Overview
      • Ensereptide – Prevention of Post-Surgical Adhesions and Scars
      • Ropocamptide – Healing of Chronic Wounds
      • Publications
  • Investors
    Investors
      • Promore Pharma on Nasdaq First North Growth Market
        • Certified Adviser
      • The Share
        • Shareholders
        • Warrant Programs
        • Share capital development
      • Financial Reports
      • Press Releases
      • Prospectuses
      • Presentations and Events
      • Calendar
      • Subscribe
  • Corporate Governance
    Corporate Governance
      • Corporate Governance
      • General Meeting
        • General Meetings
      • Nomination Committee
        • Nomination Committees
      • The Board of Directors
        • Board of Directors
      • The Management
        • Management
      • Remunerations and Remuneration Committee
      • Auditor and Audit Committee
      • Articles of Association
      • Certificate of Registration
  • Media
    Media
      • Press Releases
      • Imagebank
      • Promore Pharma in Media
      • Subscribe
  • Contact
    Contact
      • Office
      • Investors
      • Media
Svenska
The Company
  • Promore Pharma in Brief
  • Vision and Strategy
  • Market
  • Team
  • Board of Directors
Projects
  • Project Overview
  • Ensereptide – Prevention of Scarring
  • Ropocamptide – Healing of Chronic Wounds
  • Publications
Investors
  • Promore Pharma on Nasdaq First North Growth Market
    • Certified Adviser
  • The Share
    • Shareholders
    • Warrant Programs
    • Share capital development
  • Financial Reports
  • Press Releases
  • Prospectuses
  • Presentations and Events
  • Calendar
  • Subscribe
Corporate Governance
  • Corporate Governance
  • General Meeting
    • General Meetings
  • Nomination Committee
    • Nomination Committees
  • The Board of Directors
    • Board of Directors
  • The Management
    • Management
  • Remunerations and Remuneration Committee
  • Auditor and Audit Committee
  • Articles of Association
  • Certificate of Registration
Media
  • Press Releases
  • Imagebank
  • Promore Pharma in Media
  • Subscribe
Contact
  • Office
  • Investors
  • Media

Media

  • Press Releases
  • Imagebank
  • Promore Pharma in Media
  • Subscribe

Contact

Erik Magnusson

 Chief Financial Officer (CFO) +46 70 856 52 45

Media

Here you will find press releases, an image bank and you can subscribe to our releases. If you do not find what you are looking for, do not hesitate to contact us.

Press releases

  • November 23, 2021Interim report January – September 2021
  • November 19, 2021Invitation to Conference Call regarding Promore Pharma’s Interim Report for the Third Quarter 2021
  • November 16, 2021Nomination Committee Appointed for the Annual General Meeting 2022 in Promore Pharma
  • November 9, 2021Promore Pharma receives permits to start a phase II clinical trial regarding scar prevention
  • October 25, 2021Promore Pharma announces that scientific article has been published on clinical study results with ropocamptide for venous leg ulcers
More Press Releases

Calendar

  • February 16, 2022NB! New date! Year end report 2021
  • May 17, 2022Interim report January – March 2022
  • August 30, 2022Interim report January – June 2022
  • November 29, 2022Interim report January – September 2022
All events
The Company
  • Promore Pharma in Brief
  • Vision and Strategy
  • Market
  • Team
  • Board of Directors
Projects
  • Project Overview
  • Ensereptide – Prevention of Scarring
  • Ropocamptide – Healing of Chronic Wounds
  • Publications
Investors
  • Promore Pharma on Nasdaq First North Growth Market
  • The Share
  • Financial Reports
  • Press Releases
  • Prospectuses
  • Presentations and Events
  • Calendar
  • Subscribe
Corporate Governance
  • Corporate Governance
  • General Meeting
  • Nomination Committee
  • The Board of Directors
  • The Management
  • Remunerations and Remuneration Committee
  • Auditor and Audit Committee
  • Articles of Association
  • Certificate of Registration
Media
  • Press Releases
  • Imagebank
  • Promore Pharma in Media
  • Subscribe
Contact
  • Office
  • Investors
  • Media

Promore Pharma AB. Address: Fogdevreten 2, SE-171 65 Solna, Sweden. Phone: +46 8 124 548 59. E-mail: info@promorepharma.com. Registration number: 556639-6809.

  • Personal data
  • About cookies